Gastroesophageal reflux is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.
Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.
At present, there is no histologic test that has any practical value in the diagnosis of reflux disease. The only histologic diagnostic criteria are related to changes in the squamous epithelium which are too insensitive and nonspecific for effective patient management. It is widely recognized that columnar metaplasia of the esophagus (manifest histologically as cardiac, oxyntocardiac and intestinal epithelia) is caused by reflux. However, except for intestinal metaplasia, which is diagnostic for Barrett esophagus, these columnar epithelia are not used to diagnose reflux disease in biopsies. The reason for this is that these epithelial types are indistinguishable from "normal" "gastric" cardiac mucosa. In standard histology texts, this "normal gastric cardia" is 2-3 cm long.
In the mid-1990s, Dr. Chandrasoma and his team at USC produced autopsy data suggesting that cardiac and oxyntocardiac mucosa is normally absent from this region and that their presence in biopsies was histologic evidence of reflux disease. From
- The American Gastroenterological Association claims there are 14,500 members worldwide who are practicing physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver
- According to the American Society for Clinical Pathology, there are 12,000 board certified pathologists in the U.S.
- Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world
- Approximately 40% of the adult population of the U.S. suffers from significant heartburn and the numerous antacids advertised on national television represents an $8 billion per year drug market
Practicing pathologists and gastroenterologists; graduate students, medical students and researchers in pathology, gastroenterology, histology, and anatomy.
OVERVIEW The need for change in diagnostic criteria – changes in the concept of normalcy in the gastroesophageal junction in the past decade. Present controversy Biopsy protocols – present and future HISTOLOGIC DEFINITION OF EPITHELIAL TYPES CHANGES IN SQUAMOUS EPITHELIUM IN GERD COLUMNAR METAPLASIA OF ESOPHAGUS – TYPES The evolution of cardiac mucosa and its significance Classification of the population and grading Quantitating intestinal metaplasia REFLUX CARDITIS BARRETT (INTESTINAL) METAPLASIA CASE STUDIES Normal patient Compensated reflux Minimal reflux disease Moderate reflux disease Severe reflux disease Microscopic Barrett esophagus Short segment Barrett esophagus Long segment Barrett esophagus DIFFERENTIAL DIAGNOSTIC PROBLEMS Patient with accompanying gastritis Patient with atrophic gastritis and gastric intestinal metaplasia CK7, CK20 Mucin histochemistry DYSPLASIA AND ADENOCARCINOMA
- No. of pages:
- © Academic Press 2007
- 11th July 2007
- Academic Press
- eBook ISBN:
- Hardcover ISBN:
"This diagnostic atlas of GERD is an outstanding, beautifully illustrated contribution to the literature. It contains many thought-provoking pearls, and clinicians and pathologists interested in upper GI disease will benefit from its presence on their bookshelves. 4 Stars!" -- DOODY'S